Eusebio Manchado
机构: Research Scholar, Memorial Sloan Kettering Cancer Center (MSKCC)
每年引用次数
引用次数
引用: 3,987
H-指数: 19
I10-指数 : 21
出版物: 33
Phase 1 clinical trial of trametinib and ponatinib in patients with NSCLC harboring KRAS mutations
Kathryn C Arbour , Eusebio Manchado , Matthew J Bott , Linda Ahn
JTO Clinical and Research Reports 3 ( 1) 100256 -100256
10
2022
Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma
Zhuxuan Li , Xueqian Zhuang , Chun-Hao Pan , Yan Yan
Cancer Discovery 14 ( 2) 308 -325
4
2024
Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers
Marcus Ruscetti , Josef Leibold , Matthew J Bott , Mario Shields
Cancer Research 78 ( 10 Sup)
2018
Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction
Matthew Jones , Philipp Grosche , Andreas Floersheimer , Jérome André
Biochemistry 62 ( 7) 1321 -1329
4
2023
The regulation by kinases of the expression of human major histocompatibility class I molecules
Elliott J Brea , Claire Oh , Eusebio Manchado , Ron Gejman
Cancer Research 76 ( 14_Supplement) 4899 -4899
2016
INPP5A phosphatase is a synthetic lethal target in GNAQ and GNA11-mutant melanomas
Ahmed MO Elbatsh , Ali Amin-Mansour , Anne Haberkorn , Claudia Textor
Nature cancer 1 -19
2024
Correction: Corrigendum: In vivo engineering of oncogenic chromosomal rearrangements with the CRISPR/Cas9 system
Danilo Maddalo , Eusebio Manchado , Carla P Concepcion , Ciro Bonetti
Nature 524 ( 7566) 502 -502
7
2015
Promoter‐Driven Overexpression in Chromobacterium Vaccinii Facilitates Access to FR900359 and Yields Novel Low Abundance Analogs
Dominik Pistorius , Kathrin Buntin , Eric Weber , Etienne Richard
Chemistry–A European Journal 28 ( 8) e202103888 -e202103888
7
2022
SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors.
Hengyu Lu , Chen Liu , Roberto Velazquez , Hongyun Wang
MOLECULAR CANCER RESEARCH 18 ( 5) 52 -52
1
2020
Abstract A44: SHP2 inhibition overcomes RTK-mediated pathway reactivation in KRAS-mutant tumors treated with MEK inhibitors
Hengyu Lu , Chen Liu , Roberto Velazquez , Hongyun Wang
Molecular Cancer Research 18 ( 5_Supplement) A44 -A44
2020
Treatment of tumors expressing mutant p53
Eusebio Manchado , Susann Weissmueller , Scott W Lowe , Michael Saborowski
2017
Killing cells by targeting mitosis
E Manchado , M Guillamot , M Malumbres
Cell Death & Differentiation 19 ( 3) 369 -377
173
2012
4th, Wagenblast E, Davis CA, Moon SH, Pfister NT, Tschaharganeh DF, Kitzing T, Aust D, Markert EK, Wu J, et al. Mutant p53 drives pancreatic cancer metastasis through cell-autonomous PDGF receptor β signaling
S Weissmueller , E Manchado , M Saborowski , JP Morris
Cell 157 382 -94
22
2014